Explore other therapeutic areas
(dasiglucagon) injection 0.6 mg/0.6 mL
Store Zegalogue® in a refrigerator, 2 °C to 8 °C (36 °F to 46 °F). Keep away from the cooling element and do not freeze. Zegalogue® can be kept at room temperature between 20 °C to 25 °C (68 °F to 77 °F) for up to 12 months. Record the date when the product was removed from the refrigerator in the space provided on the protective case.2
Do not return the product to the refrigerator after storing at room temperature. Store in the provided protective case and protect from light. Discard Zegalogue® after the end of the 12-month period at room temperature storage, or after the expiration date stated on the product, whichever occurs first.2
Unused (unopened) insulin vials, devices, or cartridges inadvertently left at room temperature can be returned to refrigeration but must be used within designated days of initially being stored at room temperature (see Tables 1 and 2). Products not used within the listed time periods should be discarded.
Table 1. Recommended Storage Conditions for Insulin Analogs3-7
| Product | Before First Use Room temperature | Refrigerated (36 °F – 46 °F) | After First Use Room temperature | Refrigerated (36 °F – 46 °F) |
|---|---|---|---|---|
| NovoLog® vial (insulin aspart) injection | 28 days | Until expiration date | 28 days | 28 days |
| NovoLog® FlexPen® (insulin aspart) injection | 28 days | Until expiration date | 28 days | N/Ac |
| NovoLog® FlexTouch®d (insulin aspart) injection | 28 days | Until expiration date | 28 days | N/Ac |
| NovoLog® PenFill® (insulin aspart) injection | 28 days | Until expiration date | 28 days | N/Ac |
| NovoLog® Mix 70/30 vial (70% insulin aspart protamine and 30% insulin aspart) injectable suspension | 28 days | Until expiration date | 28 days | 28 days |
| NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine and 30% insulin aspart) injectable suspension | 14 days | Until expiration date | 14 days | N/Ac |
| Fiasp® vial (insulin aspart) injection | 28 days | Until expiration date | 28 days | 28 days |
| Fiasp® FlexTouch® (insulin aspart) injection | 28 days | Until expiration date | 28 days | 28 days |
| Levemir® vial (insulin detemir) injection | 42 days | Until expiration date | 42 days | 42 days |
| Levemir® FlexTouch® (insulin detemir) injection | 42 days | Until expiration date | 42 days | N/Ac |
| Tresiba® U-100 and U-200 FlexTouch® (insulin degludec) injection | 56 days | Until expiration date | 56 days | 56 days |
| Awiqli® FlexTouch® (insulin icodec-abae) injection | 12 weeks | Until expiration date | 12 weeks | 12 weeks |
aUnrefrigerated products should be discarded if not used within the time periods listed, whether or not they have been punctured or are in-use.
bUnused (unopened) FlexTouch®, FlexPen® and NovoLog® PenFill® inadvertently left at room temperature can be returned to refrigeration but must be used within designated days of initially being stored at room temperature.
cOnce in use, should be stored at room temperatures below 86 °F.
dNovoLog® FlexTouch® is not currently available in the United States.
Table 2. Recommended Storage Conditions for Insulin Analogs8-10
| Product | Before First Use Room temperature | Refrigerated (36 °F – 46 °F) | After First Use Room temperature | Refrigerated (36 °F – 46 °F) |
|---|---|---|---|---|
| Novolin® R vial (including ReliOn® brand)f | 42 days | Until expiration date | 42 days | N/Ag |
| Novolin® N vial (including ReliOn® brand)f | 42 days | Until expiration date | 42 days | N/Ag |
| Novolin® 70/30 vial (including ReliOn® brand)f | 42 days | Until expiration date | 42 days | N/Ag |
eUnused (unopened) product inadvertently left at room temperature can be returned to refrigeration but must be used within designated days of initially being stored at room temperature.
fReliOn® brand is manufactured by Novo Nordisk and sold exclusively at Walmart and Sam's Club Pharmacies.
gOnce in use, Novolin® vials and Novolin®/ReliOn® vials should not be refrigerated.
References
Speak to a medical representative
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.